RxDoctor Payments DataLook up a doctor →

James Krantz, MD

Family Medicine · Thurmont, MDNPI 1801992029

Payments from drug & device makers

$22,744in general payments, 2019–2025

Across 879 payments — averaging $25.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$7K
  • AstraZeneca$3K
  • Lilly USA, LLC$2K
  • Novo Nordisk$1K
  • Boehringer Ingelheim$1K
  • Pfizer$872
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)121$7,398
AstraZeneca120$2,857
Lilly USA, LLC93$1,596
Novo Nordisk78$1,386
Boehringer Ingelheim57$1,180
Pfizer36$872
Amgen(2 entities)38$761
GSK34$693
Astellas Pharma US Inc18$581
Sanofi-aventis U.S. LLC27$418
Medtronic10$398
Johnson & Johnson32$364
Merck23$355
Takeda Pharmaceuticals U.S.A., Inc.15$283
Esperion Therapeutics, Inc.13$272
Amarin Pharma, Inc.14$266
Eisai Inc.12$260
E.r. Squibb & Sons, L.L.C.2$215
Kowa Pharmaceuticals America, Inc.21$202
Novartis9$172
Abbott8$169
Bayer6$161
Sunovion Pharmaceuticals Inc.7$158
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$149
Biohaven Pharmaceutical Holding Company Ltd.8$135
Idorsia Pharmaceuticals US Inc6$116
Daiichi Sankyo Inc.4$113
Sumitomo Pharma America, Inc.5$110
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$93
Exact Sciences3$87
Lifescan, Inc.3$85
Biohaven Pharmaceuticals, Inc.4$84
Xeris Pharmaceuticals, Inc.3$66
Genentech USA, Inc.3$51
Axsome Therapeutics, Inc.2$50
Seqirus USA Inc3$48
Amneal Pharmaceuticals LLC2$36
Melinta Therapeutics, LLC1$32
GRT US Holding, Inc.1$29
Gilead2$28
Cranial Technologies, Inc2$28
Vanda Pharmaceuticals Inc.1$26
Optinose US, Inc.1$25
Teva Pharmaceuticals USA, Inc.2$25
Dexcom, Inc.1$25
Lundbeck LLC1$23
Assertio Therapeutics, Inc.1$23
Biotronik NRO, Inc.1$22
Radius Health, Inc.1$21
Almatica Pharma LLC1$21
Nevro Corp.1$21
Tactile Systems Technology Inc1$21
Paratek Pharmaceuticals, Inc.1$20
Corcept Therapeutics1$20
Athena Bioscience, LLC1$19
Circassia Inc.1$16
Vistapharm, Inc.1$15
Hikma Pharmaceuticals USA1$15
Currax Pharmaceuticals LLC1$14
Nabriva Therapeutics, PLC1$13

How this compares

$22,744 in reported general payments places this provider in the 95th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$316,776
Medicare patients
880
Services billed
6,738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Thurmont

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →